COVENTRY: Margaret Keenan, 90, is applauded by staff at the University Hospital on Tuesday after becoming the first person in Britain to receive the Covid-19 vaccine, produced by Pfizer and BioNTech, at the start of the largest immunisation programme in British history. Britain is the first country in the world to start vaccinating people against Covid-19 with the Pfizer/BioNTech jab.—Reuters
COVENTRY: Margaret Keenan, 90, is applauded by staff at the University Hospital on Tuesday after becoming the first person in Britain to receive the Covid-19 vaccine, produced by Pfizer and BioNTech, at the start of the largest immunisation programme in British history. Britain is the first country in the world to start vaccinating people against Covid-19 with the Pfizer/BioNTech jab.—Reuters

LONDON: Britain became the first Western country to start a mass coronavirus vaccine campaign on Tuesday with a 90-year-old receiving the initial jab, as the number of cases in Europe hit 20 million.

Kicking off Britain’s “V-Day”, Margaret Keenan said she felt “privileged” to be given the injection, the first of millions expected to be administered in the hard-hit country over the coming months.

The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5m people worldwide and ravaged economies.

“My advice to anyone offered the vaccine is to take it,” said Keenan, wearing a mask and a penguin T-shirt. “If I can have it at 90 then you can have it too.”

The UK’s second jab reportedly went to a man named William Shakespeare. The over-80s, care home workers, and at-risk health and social care staff will be at the front of the line.

Almost 40 per cent of the new cases detected over the last seven days worldwide have been in Europe, the region topping 20m cases on Tuesday. But the rate of infection appears to be stabilising.

Russia, one of Europe’s hardest-hit countries in terms of cases, began vaccinating high-risk workers with its own jab on Saturday, and Beijing has also begun an emergency inoculation campaign with a medicine made in China.

The United States is expected to grant emergency authorisation for the Pfizer-BioNTech vaccine later this week, announcing on Tuesday that no concerns had been found in trial data.

Despite the vaccination news, curbs continue to be re-imposed — roughly 30m people in the US state of California are now under stay-at-home orders.

And the World Health Organisation has warned that successful vaccines on their own will not immediately end the crisis.

America’s floundering efforts to quell the pandemic have been widely criticised — the nation is the world’s worst-hit with more than 283,000 deaths.

California ordered most offices to close and banned gatherings among different households. Bars and services such as hair salons were shut and restaurants were allowed to serve takeaway only.

Non-essential travel was also temporarily restricted statewide as California experienced record new Covid-19 cases.

“The overwhelming majority of Californians are now in this new stay-at-home order protocol,” said state Governor Gavin Newsom, who earlier warned that the state hospital system risked being overwhelmed.

The US Food and Drug Administration on Tuesday said data from trials of Pfizer-BioNTech drug revealed “no specific safety concerns”.

The data “suggest a favourable safety profile, with no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorisation)”, it said.

The FDA is also expected to give the green light to the Moderna vaccine. Canadian Prime Minister Justin Trudeau said Pfizer and BioNTech will deliver their first doses to his nation within weeks.

In India, two pharmaceutical firms — including Serum Institute, the world’s biggest manufacturer of vaccines — on Monday sought fast-track approval for coronavirus shots.

India is the second-worst hit nation having already recorded more than 140,000 deaths.

And in Brazil’s Sao Paulo state — Latin America’s coronavirus epicentre — authorities will launch a campaign from January providing the Chinese-developed vaccine CoronaVac to healthcare workers, older people and other vulnerable groups first.

Published in Dawn, December 9th, 2020

Opinion

Who bears the cost?

Who bears the cost?

This small window of low inflation should compel a rethink of how the authorities and employers understand the average household’s

Editorial

Internet restrictions
23 Dec, 2024

Internet restrictions

JUST how much longer does the government plan on throttling the internet is a question up in the air right now....
Bangladesh reset
23 Dec, 2024

Bangladesh reset

THE vibes were positive during Prime Minister Shehbaz Sharif’s recent meeting with Bangladesh interim leader Dr...
Leaving home
23 Dec, 2024

Leaving home

FROM asylum seekers to economic migrants, the continuing exodus from Pakistan shows mass disillusionment with the...
Military convictions
Updated 22 Dec, 2024

Military convictions

Pakistan’s democracy, still finding its feet, cannot afford such compromises on core democratic values.
Need for talks
22 Dec, 2024

Need for talks

FOR a long time now, the country has been in the grip of relentless political uncertainty, featuring the...
Vulnerable vaccinators
22 Dec, 2024

Vulnerable vaccinators

THE campaign to eradicate polio from Pakistan cannot succeed unless the safety of vaccinators and security personnel...